EAU 2013 - Programme Book - YouMed

Sponsored Sessions
Sunday, 17 March
412 Programme Book
Sponsored Session
17.45 - 19.15 Towards individualisation of prostate cancer treatments: From bench
to bedside
Brown Hall 3 - Level S2
Symposium
Chair: P. Hammerer, Braunschweig (DE)
Introduction
P. Hammerer, Braunschweig (DE)
Learnings from breast cancer management in treatment indivualisation (biology and treatment strategy)
G. Curigliano, Milan (IT)
Biology on prostate cancer: Will future biomarkers kill PSA?
L. Martínez Piñeiro, Madrid (ES)
A. Thompson, London (GB)
Enhanced individualisation through new strategies in CRPC
M. Eisenberger, Baltimore (US)
Treatment individualisation up to patient support
P. Hammerer, Braunschweig (DE)
Aims and objectives
The goal of this symposium is to promote the individualized approach of prostate cancer treatment. Learning
from the treatment individualization approach in breast cancer management could generate new possibilities
to stratify prostate cancer with regards to its aggressiveness. The introduction of targeted therapeutics into
the clinical therapeutic arsenal generates major opportunities for further development of cancer biomarkers.
Finally, the arrival of new hormonal pathway targeting drugs will stimulate the development of new
treatment strategies leading to a more individualized treatment of prostate cancer patients.
Sponsored by IPSEN